
Location: United States – East Coast, West Coast, and Central regions
Work Arrangement: Hybrid – on-site and remote monitoring
Duration: Long-term, flexible engagement expected to grow through 2027 as studies enroll
Openings: 3 Consultants (1 per region)
Start: March 2027, with onboarding and training possible beforehand
Schedule: Part-time to start, with potential to increase study dedication as workload grows
Travel: Regional travel to clinical sites for on-site monitoring visits
We are seeking three experienced Clinical Research Associates to provide regional monitoring support for a clinical-stage biotechnology organization moving early-phase programs into clinical development. The pipeline includes Phase 1 studies, with several programs advancing into Phase 2.
Consultants will support a portfolio of trials that includes a study resuming enrollment in March 2027 and additional studies expected to begin enrollment in Q3 2027. Planned Phase 2 studies focus on inflammatory bowel disease (IBD) and idiopathic pulmonary fibrosis (IPF). Some involve smaller patient populations, so enrollment may be gradual.
The organization uses a regional model: each CRA covers sites in their own part of the country rather than traveling nationwide. Engagements will start at a limited level and grow as sites activate and enrollment increases. This makes the role a strong fit for CRAs who want flexible, part-time work with room to grow.
Monitoring will include both on-site and remote work. The final mix is still being set with sites, but at least half of monitoring days are currently expected to be on site.
Each consultant is assigned to their own region so travel stays manageable and cross-country trips are kept to a minimum.
The ideal consultant is an experienced CRA based in one of the coverage regions, with gastroenterology or IPF monitoring experience and exposure to multiple EDC platforms. They are comfortable starting part-time and can scale up as enrollment grows.

Finding top talent in the hyper-competitive life science industries gets harder each day. With thousands of resources worldwide, hundreds of whom are former FDA, we meet your precise resourcing needs through a fast, convenient talent selection process supported by a Total Quality Guarantee.
Why is The FDA Group in business?
The FDA Group is in business to enhance the quality of people’s lives. Whether it is our clients, employees, contractors, vendors, communities, or the patients who receive the products we touch, our purpose lies in discovering meaningful ways to apply our experience, expertise, and passion for quality in everything we do.
How does The FDA Group do it?
We are able to do this through our proprietary talent selection process and deep-rooted corporate culture built upon 5 Core Values. These Core Values are the heartbeat of our organization and focus on the following concepts:
1. Respond with urgency.
2. Find a way to make it happen.
3. Communicate openly and honestly.
4. Be humbly confident.
5. Be easy to work with.
What does The FDA Group do?
The FDA Group is a leader in Global Quality & Regulatory Compliance with a focus on the rapid identification of full-time Quality, Regulatory, Engineering, and Manufacturing professionals at a competitive rate.
Since 2007, we've been documenting and excluding consultants who don't meet our high standards—protecting your projects from poor performance, lack of integrity, and slow response times. By suppressing these consultants from client engagements, we maintain a network of top-tier professionals that consistently deliver exceptional results.
Talk to us when you're ready for a better talent resourcing experience and the peace of mind that comes with a partner whose commitment to quality and integrity reflects your own.